Downregulated miRNA-491-3p accelerates colorectal cancer growth by increasing uMtCK expression

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Colorectal carcinoma (CRC) is a major global health concern.
• Tumor-suppressive microRNA-491-3p (miR-491-3p) is dysregulated in CRC.
• Increased ubiquitous mitochondrial creatine kinase (uMtCK) expression promotes CRC cell proliferation.

Purpose of the Study:

• To investigate the role of aberrant miR-491-3p expression in colorectal cancer progression.
• To determine if miR-491-3p regulates uMtCK in CRC.
• To explore the potential of miR-491-3p as a therapeutic target for CRC.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to assess miR-491-3p and uMtCK levels in CRC tissues.
• Colony formation assays and mouse xenograft models to evaluate the biological roles of miR-491-3p and uMtCK.
• Luciferase reporter assays to confirm the binding of miR-491-3p to the 3'-UTR of uMtCK.

Main Results:

• miR-491-3p expression was significantly decreased in CRC tissues, while uMtCK expression was increased.
• Overexpression of miR-491-3p inhibited CRC cell growth, whereas its depletion promoted proliferation.
• uMtCK positively regulated CRC cell proliferation, and miR-491-3p post-transcriptionally downregulated uMtCK.
• Restoring uMtCK expression abolished the tumor-suppressive effects of miR-491-3p.

Conclusions:

• miR-491-3p functions as a tumor suppressor in colorectal cancer by repressing uMtCK expression.
• The miR-491-3p/uMtCK axis represents a potential therapeutic strategy for CRC treatment.